LLY's move to buy Verve ignites investor interest across gene-editing stocks like CRSP, NTLA and BEAM in a booming M&A year.

Precision gene editing is crucial for treating genetic diseases, as it enables targeted correction of specific mutations. A ...

Delve into what the new CRISPR tool, CAST, has to offer. CRISPR-associated transposases are already gaining traction in ...

Your DNA is continually damaged by sources both inside and outside your body. One especially severe form of damage called a ...

The promise of genome editing to help understand human diseases and create new therapies is vast, but technological ...

Genome editing technologies such as CRISPR/Cas9, base editing, and prime editing are rapidly transforming our ability to ...

Japanese researchers have successfully eliminated the extra chromosome responsible for Down syndrome using CRISPR gene ...

In a global first for Africa, UCT is participating in a clinical trial to reprogramme genes and halt hereditary angioedema.

Scientists have used Site-Directed Nuclease 1 and Site-Directed Nuclease 2 (SDN-1 and SDN-2) genome editing techniques to ...

For his DC-PGE project (DNA-binding domain Conditioned Precision Genome Editing), Prof. Frank Buchholz has been awarded an Advanced Grant from the European Research Council (ERC), the highest endowed ...

In a study published in Plant Biotechnology Journal, researchers from McGill University share their findings in oat DNA, a ...